Evidence map›Paper›PMID 42337331›Full record

ArticleEuropean journal of human genetics : EJHG2026

Identifying genetic causes and establishing a diagnostic approach for WES-negative pediatric population with neurodevelopmental disorder.

Yeseul Kim, Joowon Jang, Kyeong Seon Ryu, Jong-Hee Chae, Jung Min Ko, Man Jin Kim, Seungbok Lee, Jangsup Moon, Jin Sook Lee, Hoyeon Lee and 9 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yeseul KimDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.ORCID http://orcid.org/0000-0002-6870-9214
Joowon JangDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.ORCID http://orcid.org/0000-0003-4927-7222
Kyeong Seon RyuDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Jong-Hee ChaeDepartment of Genomic Medicine, Seoul National University Hospital, Seoul, Korea.ORCID http://orcid.org/0000-0002-9162-0138
Jung Min KoDepartment of Genomic Medicine, Seoul National University Hospital, Seoul, Korea.ORCID http://orcid.org/0000-0002-0407-7828
Man Jin KimDepartment of Genomic Medicine, Seoul National University Hospital, Seoul, Korea.
Seungbok LeeDepartment of Genomic Medicine, Seoul National University Hospital, Seoul, Korea.
Jangsup MoonDepartment of Genomic Medicine, Seoul National University Hospital, Seoul, Korea.ORCID http://orcid.org/0000-0003-1282-4528
Jin Sook LeeDepartment of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
Hoyeon LeeDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.ORCID http://orcid.org/0000-0002-1026-1744
Sung Im ChoDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Seung Won ChaeCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.ORCID http://orcid.org/0000-0002-5072-8679
Hansol LimCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Hara LimCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Hobin SungCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.ORCID http://orcid.org/0009-0006-8338-0716
Seonhoo YounCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Hyesu LeeCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Jee-Soo LeeDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. leciel85@snu.ac.kr.
Moon-Woo SeongDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. mwseong@snu.ac.kr.ORCID http://orcid.org/0000-0003-2954-3677

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global developmental delay (GDD) and intellectual disability (ID) are frequently caused by genetic factors, yet many patients remain undiagnosed even after whole exome sequencing (WES). This study aimed to apply Optical Genome Mapping (OGM) and Illumina Complete Long Reads (ICLR) in pediatric patients with unexplained GDD/ID after WES and propose a practical diagnostic strategy for clinical implementation. We conducted OGM and ICLR on 87 pediatric patients with unexplained GDD/ID despite prior WES. Discordant cases underwent further validation using gap-PCR or PacBio long-read sequencing. A minigene assay was also performed to confirm the pathogenicity of an intronic variant. Of the 87 patients, 6 were found to carry pathogenic or likely pathogenic variants, including 4 structural variants (SVs) and 2 single nucleotide variants (SNVs). OGM and ICLR provided additional diagnostic yields of 4.71% and 6.98%. OGM was effective in detecting complex rearrangements, whereas ICLR performed well in cases with overlapping structural variants. For all SV burden, ICLR detected 8 SVs (mean 0.09 ± 0.33 per sample), and OGM identified 8 SVs (mean 0.09 ± 0.29 per sample), showing comparable results. This study demonstrates the complementary utility of ICLR and OGM in detecting diverse classes of pathogenic variants in GDD/ID. ICLR was advantageous for detecting non-coding SNVs, as well as for providing accurate breakpoint resolution in SVs, while OGM was effective for complex rearrangements and repetitive regions. These findings support a stepwise diagnostic strategy in which ICLR may be considered as an early second-tier test for WES-negative GDD/ID cases.

Indexed as

Developmental DisabilitiesExome SequencingGenetic TestingIntellectual DisabilityNeurodevelopmental DisordersAdolescentChildChild, PreschoolChromosome MappingFemaleHumansMale

Identifiers

PMID42337331
PMCPMC13424310

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.